Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial

✍ Scribed by Steenholdt, Casper (author);Brynskov, Jørn (author);Thomsen, Ole Østergaard (author);Munck, Lars Kristian (author);Fallingborg, Jan (author);Christensen, Lisbet Ambrosius (author);Pedersen, Gitte (author);Kjeldsen, Jens (author);Jacobsen, Bent Ascanius (author);Oxholm, Anne Sophie (author);Kjellberg, Jakob (author);Bendtzen, Klaus (author);Ainsworth, Mark Andrew (author)

• Book ID: 125495489
• Publisher: BMJ Publishing Group
• Year: 2013
• Tongue: English
• Weight: 518 KB
• Volume: 63
• Category: Article
• ISSN: 0017-5749
• DOI: 10.1136/gutjnl-2013-305279